BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Segnan N, Senore C, Andreoni B, Azzoni A, Bisanti L, Cardelli A, Castiglione G, Crosta C, Ederle A, Fantin A, Ferrari A, Fracchia M, Ferrero F, Gasperoni S, Recchia S, Risio M, Rubeca T, Saracco G, Zappa M;  SCORE3 Working Group-Italy. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology. 2007;132:2304-2312. [PMID: 17570205 DOI: 10.1053/j.gastro.2007.03.030] [Cited by in Crossref: 168] [Cited by in F6Publishing: 144] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Allison JE. Colorectal Cancer Screening Guidelines: The Importance of Evidence and Transparency. Gastroenterology 2010;138:1648-1652.e2. [DOI: 10.1053/j.gastro.2010.03.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
2 Gawron AJ, Yadlapati R. Disparities in endoscopy use for colorectal cancer screening in the United States. Dig Dis Sci 2014;59:530-7. [PMID: 24248417 DOI: 10.1007/s10620-013-2937-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
3 Sweet A, Lee D, Gairy K, Phiri D, Reason T, Lock K. The impact of CT colonography for colorectal cancer screening on the UK NHS: costs, healthcare resources and health outcomes. Appl Health Econ Health Policy. 2011;9:51-64. [PMID: 21174482 DOI: 10.2165/11588110-000000000-00000] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
4 Steele RJ, Mcdonald P. Screening for Colorectal Cancer. In: Scholefield JH, Eng C, editors. Colorectal Cancer. Chichester: John Wiley & Sons, Ltd; 2014. pp. 27-50. [DOI: 10.1002/9781118337929.ch2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Buskermolen M, Cenin DR, Helsingen LM, Guyatt G, Vandvik PO, Haug U, Bretthauer M, Lansdorp-Vogelaar I. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study. BMJ 2019;367:l5383. [PMID: 31578177 DOI: 10.1136/bmj.l5383] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 12.5] [Reference Citation Analysis]
6 Castells A, Bessa X, Quintero E, Bujanda L, Cubiella J, Salas D, Lanas Á, Carballo F, Morillas JD, Hernández C, Jover R, Montalvo I, Arenas J, Cosme Á, Hernández V, Iglesias B, Castro I, Cid L, Sala T, Ponce M, Andrés M, Teruel G, Peris A, Roncales M, González-rubio F, Seoane-urgorri A, Grau J, Serradesanferm A, Pellisé M, Ono A, Cruzado J, Pérez-riquelme F, Alonso-abreu I, Carrillo-palau M, de la Vega-prieto M, Iglesias R, Amador J, Blanco JM, Sastre R, Ferrándiz J, González-hernández MJ, Andreu M. Risk of Advanced Proximal Neoplasms According to Distal Colorectal Findings: Comparison of Sigmoidoscopy-Based Strategies. JNCI: Journal of the National Cancer Institute 2013;105:878-86. [DOI: 10.1093/jnci/djt117] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
7 Zarchy T. Colonoscopy Screening in Average-Risk Individuals Ages 40–49 Versus 50–59 Years. Gastroenterology 2008;135:1016-7. [DOI: 10.1053/j.gastro.2008.06.086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Doria-Rose VP, Laiyemo AO, Church T, Yokochi LA, Yurgalevitch S, Rathmell J, Andriole GL, Buys S, Crawford ED, Fouad M, Isaacs C, Lamerato L, Reding D, Prorok PC, Berg CD; PLCO Project Team. Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination. J Natl Cancer Inst. 2012;104:280-289. [PMID: 22298838 DOI: 10.1093/jnci/djr549] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
9 Carozzi FM, Sani C. Fecal Collection and Stabilization Methods for Improved Fecal DNA Test for Colorectal Cancer in a Screening Setting. Journal of Cancer Research 2013;2013:1-8. [DOI: 10.1155/2013/818675] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
10 Takashima K, Komeda Y, Sakurai T, Masaki S, Nagai T, Matsui S, Hagiwara S, Takenaka M, Nishida N, Kashida H, Nakaji K, Watanabe T, Kudo M. Castor oil as booster for colon capsule endoscopy preparation reduction: A prospective pilot study and patient questionnaire. World J Gastrointest Pharmacol Ther 2021; 12(4): 79-89 [PMID: 34316385 DOI: 10.4292/wjgpt.v12.i4.79] [Reference Citation Analysis]
11 Sali L, Regge D. CT colonography for population screening of colorectal cancer: hints from European trials. Br J Radiol. 2016;89:20160517. [PMID: 27542076 DOI: 10.1259/bjr.20160517] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
12 Senore C, Bellisario C, Segnan N. Distribution of colorectal polyps: Implications for screening. Best Practice & Research Clinical Gastroenterology 2017;31:481-8. [DOI: 10.1016/j.bpg.2017.04.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
13 Iafrate F, Hassan C, Ciolina M, Lamazza A, Baldassari P, Pichi A, Zullo A, Stagnitti A, Iannitti M, Rengo M. High positive predictive value of CT colonography in a referral centre. Eur J Radiol. 2011;80:e289-e292. [PMID: 21324624 DOI: 10.1016/j.ejrad.2010.12.080] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
14 de Haan MC, Halligan S, Stoker J. Does CT colonography have a role for population-based colorectal cancer screening? Eur Radiol 2012;22:1495-503. [PMID: 22549102 DOI: 10.1007/s00330-012-2449-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
15 Robertson DJ, Lee JK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Lieberman D, Levin TR, Rex DK. Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017;112:37-53. [PMID: 27753435 DOI: 10.1038/ajg.2016.492] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
16 Sali L, Grazzini G, Carozzi F, Castiglione G, Falchini M, Mallardi B, Mantellini P, Ventura L, Regge D, Zappa M. Screening for colorectal cancer with FOBT, virtual colonoscopy and optical colonoscopy: study protocol for a randomized controlled trial in the Florence district (SAVE study). Trials. 2013;14:74. [PMID: 23497601 DOI: 10.1186/1745-6215-14-74] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
17 van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008;135:82-90. [PMID: 18482589 DOI: 10.1053/j.gastro.2008.03.040] [Cited by in Crossref: 486] [Cited by in F6Publishing: 421] [Article Influence: 37.4] [Reference Citation Analysis]
18 Littlejohn C, Hilton S, Macfarlane GJ, Phull P. Systematic review and meta-analysis of the evidence for flexible sigmoidoscopy as a screening method for the prevention of colorectal cancer. Br J Surg. 2012;99:1488-1500. [PMID: 23001715 DOI: 10.1002/bjs.8882] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
19 Sassoli de Bianchi P, Campari C, Mancini S, Giuliani O, Landi P, Paterlini L, Naldoni C, Finarelli AC, Falcini F, Ponz de Leon M. Colonoscopic surveillance of first-degree relatives of colorectal cancer patients in a faecal occult blood screening programme. Cancer Epidemiol. 2013;37:469-473. [PMID: 23683843 DOI: 10.1016/j.canep.2013.04.004] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
20 Faivre J, Dancourt V, Manfredi S, Denis B, Durand G, Gendre I, Bidan JM, Jard C, Levillain R, Jung S. Positivity rates and performances of immunochemical faecal occult blood tests at different cut-off levels within a colorectal cancer screening programme. Dig Liver Dis. 2012;44:700-704. [PMID: 22542582 DOI: 10.1016/j.dld.2012.03.015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
21 Hassan C, Giorgi Rossi P, Camilloni L, Rex DK, Jimenez-Cendales B, Ferroni E, Borgia P, Zullo A, Guasticchi G. Meta-analysis: adherence to colorectal cancer screening and the detection rate for advanced neoplasia, according to the type of screening test. Aliment Pharmacol Ther. 2012;36:929-940. [PMID: 23035890 DOI: 10.1111/apt.12071] [Cited by in Crossref: 89] [Cited by in F6Publishing: 68] [Article Influence: 9.9] [Reference Citation Analysis]
22 Denis B, Gendre I, Aman F, Ribstein F, Maurin P, Perrin P. Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: A French population-based controlled study (Wintzenheim trial). European Journal of Cancer 2009;45:3282-90. [DOI: 10.1016/j.ejca.2009.06.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
23 Knudsen MD, de Lange T, Botteri E, Nguyen DH, Evensen H, Steen CB, Hoff G, Bernklev T, Hjartåker A, Berstad P. Favorable lifestyle before diagnosis associated with lower risk of screen-detected advanced colorectal neoplasia. World J Gastroenterol 2016; 22(27): 6276-6286 [PMID: 27468217 DOI: 10.3748/wjg.v22.i27.6276] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
24 Dancourt V, Lejeune C, Lepage C, Gailliard MC, Meny B, Faivre J. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms. European Journal of Cancer 2008;44:2254-8. [DOI: 10.1016/j.ejca.2008.06.041] [Cited by in Crossref: 69] [Cited by in F6Publishing: 60] [Article Influence: 5.3] [Reference Citation Analysis]
25 Castro I, Estevez P, Cubiella J, Hernandez V, González-Mao C, Rivera C, Iglesias F, Cid L, Soto S, de-Castro L, Vega P, Hermo JA, Macenlle R, Martínez A, Cid E, Gil I, Larzabal M, Bujanda L, Castells A; COLONPREV study investigators. Diagnostic performance of fecal immunochemical test and sigmoidoscopy for advanced right-sided colorectal neoplasms. Dig Dis Sci 2015;60:1424-32. [PMID: 25407805 DOI: 10.1007/s10620-014-3434-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
26 Pasha SF. Applications of Colon Capsule Endoscopy. Curr Gastroenterol Rep. 2018;20:22. [PMID: 29644509 DOI: 10.1007/s11894-018-0628-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
27 Hassan C, Kaminski MF, Repici A. How to Ensure Patient Adherence to Colorectal Cancer Screening and Surveillance in Your Practice. Gastroenterology 2018;155:252-7. [PMID: 29964039 DOI: 10.1053/j.gastro.2018.06.051] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
28 Regge D, Iussich G, Senore C, Correale L, Hassan C, Bert A, Montemezzi S, Segnan N. Population screening for colorectal cancer by flexible sigmoidoscopy or CT colonography: study protocol for a multicenter randomized trial. Trials. 2014;15:97. [PMID: 24678896 DOI: 10.1186/1745-6215-15-97] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
29 Shi HY, Ng SC, Tsoi KK, Wu JC, Sung JJ, Chan FK. The role of capsule endoscopy in assessing mucosal inflammation in ulcerative colitis. Expert Rev Gastroenterol Hepatol. 2015;9:47-54. [PMID: 24966092 DOI: 10.1586/17474124.2014.934359] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
30 Castells A. Choosing the optimal method in programmatic colorectal cancer screening: current evidence and controversies. Therap Adv Gastroenterol 2015;8:221-33. [PMID: 26136839 DOI: 10.1177/1756283X15578610] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
31 Radaelli F, Paggi S, Hassan C, Senore C, Fasoli R, Anderloni A, Buffoli F, Savarese MF, Spinzi G, Rex DK, Repici A. Split-dose preparation for colonoscopy increases adenoma detection rate: a randomised controlled trial in an organised screening programme. Gut 2017;66:270-7. [DOI: 10.1136/gutjnl-2015-310685] [Cited by in Crossref: 67] [Cited by in F6Publishing: 56] [Article Influence: 11.2] [Reference Citation Analysis]
32 Viiala CH, Olynyk JK. Outcomes after 10 years of a community‐based flexible sigmoidoscopy screening program for colorectal carcinoma. Medical Journal of Australia 2007;187:274-7. [DOI: 10.5694/j.1326-5377.2007.tb01241.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
33 den Hoed CM, Isendoorn K, Klinkhamer W, Gupta A, Kuipers EJ. The societal gain of medical development and innovation in gastroenterology. United European Gastroenterol J 2013;1:335-45. [PMID: 24917981 DOI: 10.1177/2050640613502337] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
34 Pilonis ND, Bugajski M, Wieszczy P, Rupinski M, Pisera M, Pawlak E, Regula J, Kaminski MF. Participation in Competing Strategies for Colorectal Cancer Screening: A Randomized Health Services Study (PICCOLINO Study). Gastroenterology 2021;160:1097-105. [PMID: 33307024 DOI: 10.1053/j.gastro.2020.11.049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Repici A, Pagano N, Hassan C, Carlino A, Rando G, Strangio G, Romeo F, Zullo A, Ferrara E, Vitetta E, Ferreira DPP, Danese S, Arosio M, Malesci A. Balanced propofol sedation administered by nonanesthesiologists: The first Italian experience. World J Gastroenterol 2011; 17(33): 3818-3823 [PMID: 21987624 DOI: 10.3748/wjg.v17.i33.3818] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
36 Parente F, Marino B, Devecchi N, Moretti R. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer. British Journal of Surgery 2009;96:533-40. [DOI: 10.1002/bjs.6568] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
37 Naito Y, Uchiyama K, Kinoshita Y, Fukudo S, Joh T, Suzuki H, Takahashi S, Ueno F, Fujiwara Y, Arakawa T, Matsumoto T, Hahm KB, Kachintorn U, Syam AF, Rani AA, Sollano JD, Zhu Q. A questionnaire-based survey on screening for gastric and colorectal cancer by physicians in East Asian countries in 2010. Digestion 2012;86:94-106. [PMID: 22846219 DOI: 10.1159/000339342] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
38 Hissong E, Pittman ME. Colorectal carcinoma screening: Established methods and emerging technology. Crit Rev Clin Lab Sci 2020;57:22-36. [PMID: 31603697 DOI: 10.1080/10408363.2019.1670614] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
39 Bhardwaj M, Weigl K, Tikk K, Benner A, Schrotz-King P, Brenner H. Multiplex screening of 275 plasma protein biomarkers to identify a signature for early detection of colorectal cancer. Mol Oncol 2020;14:8-21. [PMID: 31652396 DOI: 10.1002/1878-0261.12591] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
40 Senore C, Hassan C, Regge D, Pagano E, Iussich G, Correale L, Segnan N. Cost-effectiveness of colorectal cancer screening programmes using sigmoidoscopy and immunochemical faecal occult blood test. J Med Screen 2019;26:76-83. [PMID: 30180780 DOI: 10.1177/0969141318789710] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
41 Senore C, Armaroli P, Silvani M, Andreoni B, Bisanti L, Marai L, Castiglione G, Grazzini G, Taddei S, Gasperoni S. Comparing different strategies for colorectal cancer screening in Italy: predictors of patients’ participation. Am J Gastroenterol. 2010;105:188-198. [PMID: 19826409 DOI: 10.1038/ajg.2009.583] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 4.4] [Reference Citation Analysis]
42 van Rossum LG, van Rijn AF, Verbeek AL, van Oijen MG, Laheij RJ, Fockens P, Jansen JB, Adang EM, Dekker E. Colorectal cancer screening comparing no screening, immunochemical and guaiac fecal occult blood tests: a cost-effectiveness analysis. Int J Cancer 2011;128:1908-17. [PMID: 20589677 DOI: 10.1002/ijc.25530] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
43 Stratmann K, Bock H, Filmann N, Fister P, Weber C, Tacke W, Simonis B, Höftmann M, Schröder O, Hausmann J, Zeuzem S, Blumenstein I. Individual invitation letters lead to significant increase in attendance for screening colonoscopies: Results of a pilot study in Northern Hesse, Germany. United European Gastroenterol J 2018;6:1082-8. [PMID: 30228897 DOI: 10.1177/2050640618769713] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
44 Sieg A, Friedrich K. Perspectives of colorectal cancer screening in Germany 2009. World J Gastrointest Endosc 2009; 1(1): 12-16 [PMID: 21160645 DOI: 10.4253/wjge.v1.i1.12] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
45 Knudsen MD, Berstad P, Hjartåker A, Gulichsen EH, Hoff G, de Lange T, Bernklev T, Botteri E. Lifestyle predictors for non-participation and outcome in the second round of faecal immunochemical test in colorectal cancer screening. Br J Cancer 2017;117:461-9. [PMID: 28704841 DOI: 10.1038/bjc.2017.189] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
46 de Wijkerslooth TR, de Haan MC, Stoop EM, Deutekom M, Fockens P, Bossuyt PM, Thomeer M, van Ballegooijen M, Essink-Bot ML, van Leerdam ME, Kuipers EJ, Dekker E, Stoker J. Study protocol: population screening for colorectal cancer by colonoscopy or CT colonography: a randomized controlled trial. BMC Gastroenterol 2010;10:47. [PMID: 20482825 DOI: 10.1186/1471-230X-10-47] [Cited by in Crossref: 45] [Cited by in F6Publishing: 18] [Article Influence: 4.1] [Reference Citation Analysis]
47 Spada C, Hassan C, Marmo R, Petruzziello L, Riccioni ME, Zullo A, Cesaro P, Pilz J, Costamagna G. Meta-analysis shows colon capsule endoscopy is effective in detecting colorectal polyps. Clin Gastroenterol Hepatol. 2010;8:516-522. [PMID: 20215066 DOI: 10.1016/j.cgh.2010.02.018] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 5.7] [Reference Citation Analysis]
48 Spada C, Hassan C, Munoz-Navas M, Neuhaus H, Deviere J, Fockens P, Coron E, Gay G, Toth E, Riccioni ME, Carretero C, Charton JP, Van Gossum A, Wientjes CA, Sacher-Huvelin S, Delvaux M, Nemeth A, Petruzziello L, de Frias CP, Mayershofer R, Amininejad L, Dekker E, Galmiche JP, Frederic M, Johansson GW, Cesaro P, Costamagna G. Second-generation colon capsule endoscopy compared with colonoscopy. Gastrointest Endosc 2011; 74: 581-589. e1. [PMID: 21601200 DOI: 10.1016/j.gie.2011.03.1125] [Cited by in Crossref: 159] [Cited by in F6Publishing: 136] [Article Influence: 15.9] [Reference Citation Analysis]
49 Salas D, Vanaclocha M, Ibáñez J, Molina-Barceló A, Hernández V, Cubiella J, Zubizarreta R, Andreu M, Hernández C, Pérez-Riquelme F, Cruzado J, Carballo F, Bujanda L, Sarasqueta C, Portillo I, de la Vega-Prieto M, Morillas JD, Valentín V, Lanas A, Quintero E, Castells A. Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening. Cancer Causes Control 2014;25:985-97. [PMID: 24859111 DOI: 10.1007/s10552-014-0398-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
50 Franz M, Scholz M, Henze I, Röckl S, Gomez LI. Detection of colon polyps by a novel, polymer pattern-based full blood test. J Transl Med 2013;11:278. [PMID: 24180554 DOI: 10.1186/1479-5876-11-278] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
51 Faivre J, Dancourt V, Denis B, Dorval E, Piette C, Perrin P, Bidan JM, Jard C, Jung S, Levillain R, Viguier J, Bretagne JF. Comparison between a guaiac and three immunochemical faecal occult blood tests in screening for colorectal cancer. Eur J Cancer 2012;48:2969-76. [PMID: 22572481 DOI: 10.1016/j.ejca.2012.04.007] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 6.0] [Reference Citation Analysis]
52 Adler S, Hassan C, Metzger Y, Sompolinsky Y, Spada C. Accuracy of automatic detection of small-bowel mucosa by second-generation colon capsule endoscopy. Gastrointestinal Endoscopy 2012;76:1170-4. [DOI: 10.1016/j.gie.2012.07.034] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
53 van Dam L, Bretthauer M. Ethical issues in colorectal cancer screening. Best Pract Res Clin Gastroenterol 2014;28:315-26. [PMID: 24810192 DOI: 10.1016/j.bpg.2014.03.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
54 Zorzi M, Senore C, Da Re F, Barca A, Bonelli LA, Cannizzaro R, Fasoli R, Di Furia L, Di Giulio E, Mantellini P, Naldoni C, Sassatelli R, Rex D, Hassan C, Zappa M; the Equipe Working Group. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy). Gut 2015;64:1389-96. [DOI: 10.1136/gutjnl-2014-307954] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 7.3] [Reference Citation Analysis]
55 Huck MB, Bohl JL. Colonic Polyps: Diagnosis and Surveillance. Clin Colon Rectal Surg 2016;29:296-305. [PMID: 31777460 DOI: 10.1055/s-0036-1584091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
56 van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, Jansen JB, Verbeek AL, Dekker E. Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme. Br J Cancer. 2009;101:1274-1281. [PMID: 19755997 DOI: 10.1038/sj.bjc.6605326] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 5.7] [Reference Citation Analysis]
57 Grobbee EJ, van der Vlugt M, van Vuuren AJ, Stroobants AK, Mallant-hent RC, Lansdorp-vogelaar I, Bossuyt PM, Kuipers EJ, Dekker E, Spaander MC. Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening. Clinical Gastroenterology and Hepatology 2020;18:667-675.e1. [DOI: 10.1016/j.cgh.2019.08.015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
58 Hassan C, Senore C, Radaelli F, De Pretis G, Sassatelli R, Arrigoni A, Manes G, Amato A, Anderloni A, Armelao F. Full-spectrum (FUSE) versus standard forward-viewing colonoscopy in an organised colorectal cancer screening programme. Gut. 2016; Epub ahead of print. [PMID: 27507903 DOI: 10.1136/gutjnl-2016-311906] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
59 Sharp L, Tilson L, Whyte S, Ceilleachair AO, Walsh C, Usher C, Tappenden P, Chilcott J, Staines A, Barry M, Comber H. Using resource modelling to inform decision making and service planning: the case of colorectal cancer screening in Ireland. BMC Health Serv Res 2013;13:105. [PMID: 23510135 DOI: 10.1186/1472-6963-13-105] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
60 Bonello B, Ghanouni A, Bowyer HL, MacRae E, Atkin W, Halloran SP, Wardle J, von Wagner C. Using a hypothetical scenario to assess public preferences for colorectal surveillance following screening-detected, intermediate-risk adenomas: annual home-based stool test vs. triennial colonoscopy. BMC Gastroenterol 2016;16:113. [PMID: 27618798 DOI: 10.1186/s12876-016-0517-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
61 Massat NJ, Moss SM, Halloran SP, Duffy SW. Screening and Primary prevention of Colorectal Cancer: a Review of sex-specific and site-specific differences. J Med Screen 2013;20:125-48. [DOI: 10.1177/0969141313501292] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
62 Kim DH, Pickhardt PJ, Hanson ME, Hinshaw JL. CT Colonography: Performance and Program Outcome Measures in an Older Screening Population. Radiology 2010;254:493-500. [DOI: 10.1148/radiol.09091478] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 4.6] [Reference Citation Analysis]
63 Kashfi SM, Nazemalhosseini Mojarad E, Pourhoseingholi MA, Asadzadeh Aghdaei H, Anaraki F, Zali MR. Evaluation of the left-to-right shift of colon tumors in Iran: Is the trend changing? J Res Med Sci 2015;20:978-86. [PMID: 26929764 DOI: 10.4103/1735-1995.172789] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
64 Lin JS, Perdue LA, Henrikson NB, Bean SI, Blasi PR. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2021;325:1978-98. [PMID: 34003220 DOI: 10.1001/jama.2021.4417] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
65 Tinmouth J, Lansdorp-Vogelaar I, Allison JE. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know. Gut 2015;64:1327-37. [PMID: 26041750 DOI: 10.1136/gutjnl-2014-308074] [Cited by in Crossref: 89] [Cited by in F6Publishing: 93] [Article Influence: 14.8] [Reference Citation Analysis]
66 Kim DH, Cha JM, Kwak MS, Yoon JY, Cho YH, Jeon JW, Shin HP, Joo KR, Lee JI. Quality Metrics of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program in Korea. Gut Liver 2018;12:183-9. [PMID: 29212310 DOI: 10.5009/gnl17030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
67 Randel KR, Schult AL, Botteri E, Hoff G, Bretthauer M, Ursin G, Natvig E, Berstad P, Jørgensen A, Sandvei PK, Olsen ME, Frigstad SO, Darre-Næss O, Norvard ER, Bolstad N, Kørner H, Wibe A, Wensaas KA, de Lange T, Holme Ø. Colorectal Cancer Screening With Repeated Fecal Immunochemical Test Versus Sigmoidoscopy: Baseline Results From a Randomized Trial. Gastroenterology 2021;160:1085-1096.e5. [PMID: 33227280 DOI: 10.1053/j.gastro.2020.11.037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
68 Caviglia GP, Cabianca L, Fagoonee S, Gili FM. Colorectal cancer detection in an asymptomatic population: fecal immunochemical test for hemoglobin vs. fecal M2-type pyruvate kinase. Biochem Med (Zagreb). 2016;26:114-120. [PMID: 26981025 DOI: 10.11613/BM.2016.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Brenner H, Stock C, Hoffmeister M. In the era of widespread endoscopy use, randomized trials may strongly underestimate the effects of colorectal cancer screening. Journal of Clinical Epidemiology 2013;66:1144-50. [DOI: 10.1016/j.jclinepi.2013.05.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
70 Castells A, Quintero E, Álvarez C, Bujanda L, Cubiella J, Salas D, Lanas A, Carballo F, Morillas JD, Hernández C, Jover R, Hijona E, Portillo I, Enríquez-Navascués JM, Hernández V, Martínez-Turnes A, Menéndez-Villalva C, González-Mao C, Sala T, Ponce M, Andrés M, Teruel G, Peris A, Sopeña F, González-Rubio F, Seoane-Urgorri A, Grau J, Serradesanferm A, Pozo À, Pellisé M, Balaguer F, Ono A, Cruzado J, Pérez-Riquelme F, Alonso-Abreu I, Carrillo-Palau M, de la Vega-Prieto M, Iglesias R, Amador J, Blanco JM, Sastre R, Ferrándiz J, González-Hernández MJ, Andreu M, Bessa X; COLONPREV Study Investigators. Rate of detection of advanced neoplasms in proximal colon by simulated sigmoidoscopy vs fecal immunochemical tests. Clin Gastroenterol Hepatol 2014;12:1708-16.e4. [PMID: 24681078 DOI: 10.1016/j.cgh.2014.03.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
71 Meng W, Cai SR, Zhou L, Dong Q, Zheng S, Zhang SZ. Performance value of high risk factors in colorectal cancer screening in China. World J Gastroenterol 2009; 15(48): 6111-6116 [PMID: 20027686 DOI: 10.3748/wjg.15.6111] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
72 Leitao K, Grimstad T, Bretthauer M, Holme Ø, Paulsen V, Karlsen L, Isaksen K, Cvancarova M, Aabakken L. Polyethylene glycol vs sodium picosulfate/magnesium citrate for colonoscopy preparation. Endosc Int Open 2014;2:E230-4. [PMID: 26135098 DOI: 10.1055/s-0034-1377520] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
73 Mojica CM, Lind B, Gu Y, Coronado GD, Davis MM. Predictors of Colorectal Cancer Screening Modality Among Newly Age-Eligible Medicaid Enrollees. Am J Prev Med 2021;60:72-9. [PMID: 33223363 DOI: 10.1016/j.amepre.2020.08.003] [Reference Citation Analysis]
74 Stoop EM, de Wijkerslooth TR, Bossuyt PM, Stoker J, Fockens P, Kuipers EJ, Dekker E, van Leerdam ME. Face-to-face vs telephone pre-colonoscopy consultation in colorectal cancer screening; a randomised trial. Br J Cancer 2012;107:1051-8. [PMID: 22918392 DOI: 10.1038/bjc.2012.358] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
75 Spada C, De Vincentis F, Cesaro P, Hassan C, Riccioni ME, Minelli Grazioli L, Bolivar S, Zurita A, Costamagna G. Accuracy and safety of second-generation PillCam COLON capsule for colorectal polyp detection. Therap Adv Gastroenterol. 2012;5:173-178. [PMID: 22570677 DOI: 10.1177/1756283x12438054] [Cited by in Crossref: 28] [Cited by in F6Publishing: 7] [Article Influence: 3.1] [Reference Citation Analysis]
76 Inadomi JM, Vijan S, Janz NK, Fagerlin A, Thomas JP, Lin YV, Muñoz R, Lau C, Somsouk M, El-Nachef N, Hayward RA. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med 2012;172:575-82. [PMID: 22493463 DOI: 10.1001/archinternmed.2012.332] [Cited by in Crossref: 310] [Cited by in F6Publishing: 279] [Article Influence: 34.4] [Reference Citation Analysis]
77 Hassan C, Pickhardt PJ. Management of subcentimetric polyps detected by CT colonography. Nat Rev Gastroenterol Hepatol 2013;10:119-24. [PMID: 23165237 DOI: 10.1038/nrgastro.2012.222] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
78 Kerrison RS, von Wagner C, Green T, Gibbins M, Macleod U, Hughes M, Rees CJ, Duffy S, Mcgregor LM. Rapid review of factors associated with flexible sigmoidoscopy screening use. Preventive Medicine 2019;120:8-18. [DOI: 10.1016/j.ypmed.2018.12.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
79 Lisi D, Hassan C, Crespi M;  AMOD Study Group. Participation in colorectal cancer screening with FOBT and colonoscopy: an Italian, multicentre, randomized population study. Dig Liver Dis. 2010;42:371-376. [PMID: 19747888 DOI: 10.1016/j.dld.2009.07.019] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
80 Zhong G, Sun W, Wan L, Hu J, Hao F. Efficacy and cost-effectiveness of fecal immunochemical test versus colonoscopy in colorectal cancer screening: a systematic review and meta-analysis. Gastrointestinal Endoscopy 2020;91:684-697.e15. [DOI: 10.1016/j.gie.2019.11.035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
81 Fusco M, Pezzi A, Benatti P, Roncucci L, Chiodini P, Di Maio G, Di Napoli R, de Leon MP. Clinical features and colorectal cancer survival: An attempt to explain differences between two different Italian regions. European Journal of Cancer 2010;46:142-9. [DOI: 10.1016/j.ejca.2009.07.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
82 Ventura L, Zappa M, Carreras G, Ciatto S, Grazzini G. What is the best screening strategy to detect advanced colorectal adenomas? Simulation from ongoing Italian screening experiences. Tumori 2011;97:547-50. [DOI: 10.1177/030089161109700501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
83 van Rossum LG. Colorectal cancer screening: how to stop a moving target. Clin Gastroenterol Hepatol 2012;10:570-2. [PMID: 22441108 DOI: 10.1016/j.cgh.2012.03.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
84 Robertson DJ, Lee JK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Lieberman D, Levin TR, Rex DK. Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017;152:1217-1237.e3. [PMID: 27769517 DOI: 10.1053/j.gastro.2016.08.053] [Cited by in Crossref: 142] [Cited by in F6Publishing: 123] [Article Influence: 28.4] [Reference Citation Analysis]
85 Stoop EM, de Haan MC, de Wijkerslooth TR, Bossuyt PM, van Ballegooijen M, Nio CY, van de Vijver MJ, Biermann K, Thomeer M, van Leerdam ME, Fockens P, Stoker J, Kuipers EJ, Dekker E. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. The Lancet Oncology 2012;13:55-64. [DOI: 10.1016/s1470-2045(11)70283-2] [Cited by in Crossref: 244] [Cited by in F6Publishing: 93] [Article Influence: 27.1] [Reference Citation Analysis]
86 Kaminski MF, Bretthauer M, Zauber AG, Kuipers EJ, Adami HO, van Ballegooijen M, Regula J, van Leerdam M, Stefansson T, Påhlman L, Dekker E, Hernán MA, Garborg K, Hoff G. The NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer. Endoscopy 2012;44:695-702. [PMID: 22723185 DOI: 10.1055/s-0032-1306895] [Cited by in Crossref: 106] [Cited by in F6Publishing: 90] [Article Influence: 11.8] [Reference Citation Analysis]
87 Rat C, Latour C, Rousseau R, Gaultier A, Pogu C, Edwards A, Nguyen J. Interventions to increase uptake of faecal tests for colorectal cancer screening: a systematic review. European Journal of Cancer Prevention 2018;27:227-36. [DOI: 10.1097/cej.0000000000000344] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 7.7] [Reference Citation Analysis]
88 Levy BT, Bay C, Xu Y, Daly JM, Bergus G, Dunkelberg J, Moss C. Test characteristics of faecal immunochemical tests (FIT) compared with optical colonoscopy. J Med Screen 2014;21:133-43. [PMID: 24958730 DOI: 10.1177/0969141314541109] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
89 Regula J, Kaminski MF. Targeting risk groups for screening. Best Pract Res Clin Gastroenterol 2010;24:407-16. [PMID: 20833345 DOI: 10.1016/j.bpg.2010.06.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
90 Garborg K, Holme Ø, Løberg M, Kalager M, Adami HO, Bretthauer M. Current status of screening for colorectal cancer. Ann Oncol. 2013;24:1963-1972. [PMID: 23619033 DOI: 10.1093/annonc/mdt157] [Cited by in Crossref: 64] [Cited by in F6Publishing: 69] [Article Influence: 8.0] [Reference Citation Analysis]
91 Deibel A, Deng L, Cheng CY, Schlander M, Ran T, Lang B, Krupka N, Beerenwinkel N, Rogler G, Wiest R, Sonnenberg A, Poleszczuk J, Misselwitz B. Evaluating key characteristics of ideal colorectal cancer screening modalities: the microsimulation approach. Gastrointest Endosc 2021;94:379-390.e7. [PMID: 33600806 DOI: 10.1016/j.gie.2021.02.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
92 van Gils P, van den Berg M, van Kranen H, de Wit AG. A literature review of assumptions on test characteristics and adherence in economic evaluations of colonoscopy and CT-colonography screening. European Journal of Cancer 2009;45:1554-9. [DOI: 10.1016/j.ejca.2009.01.032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
93 Yoon JY, Cha JM, Jeen YT; Medical Policy Committee of Korean Association for the Study of Intestinal Diseases (KASID)., Quality Improvement Committee of Korean Society of Gastrointestinal Endoscopy (KSGE). Quality is the key for emerging issues of population-based colonoscopy screening. Intest Res 2018;16:48-54. [PMID: 29422797 DOI: 10.5217/ir.2018.16.1.48] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
94 Tinmouth J, Vella ET, Baxter NN, Dubé C, Gould M, Hey A, Ismaila N, McCurdy BR, Paszat L. Colorectal Cancer Screening in Average Risk Populations: Evidence Summary. Can J Gastroenterol Hepatol 2016;2016:2878149. [PMID: 27597935 DOI: 10.1155/2016/2878149] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
95 Halpern MT, Pavluck AL, Ko CY, Ward EM. Factors associated with colon cancer stage at diagnosis. Dig Dis Sci 2009;54:2680-93. [PMID: 19117126 DOI: 10.1007/s10620-008-0669-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
96 Pox CP, Altenhofen L, Brenner H, Theilmeier A, Von Stillfried D, Schmiegel W. Efficacy of a nationwide screening colonoscopy program for colorectal cancer. Gastroenterology. 2012;142:1460-1467.e2. [PMID: 22446606 DOI: 10.1053/j.gastro.2012.03.022] [Cited by in Crossref: 172] [Cited by in F6Publishing: 138] [Article Influence: 19.1] [Reference Citation Analysis]
97 Senore C, Inadomi J, Segnan N, Bellisario C, Hassan C. Optimising colorectal cancer screening acceptance: a review. Gut 2015;64:1158-77. [DOI: 10.1136/gutjnl-2014-308081] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 10.3] [Reference Citation Analysis]
98 Elmunzer BJ, Hayward RA, Schoenfeld PS, Saini SD, Deshpande A, Waljee AK. Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2012;9:e1001352. [PMID: 23226108 DOI: 10.1371/journal.pmed.1001352] [Cited by in Crossref: 134] [Cited by in F6Publishing: 124] [Article Influence: 14.9] [Reference Citation Analysis]
99 Regge D, Iussich G, Segnan N, Correale L, Hassan C, Arrigoni A, Asnaghi R, Bestagini P, Bulighin G, Cassinis MC, Ederle A, Ferraris A, Galatola G, Gallo T, Gandini G, Garretti L, Martina MC, Molinar D, Montemezzi S, Morra L, Motton M, Occhipinti P, Pinali L, Soardi GA, Senore C. Comparing CT colonography and flexible sigmoidoscopy: a randomised trial within a population-based screening programme. Gut. 2017;66:1434-1440. [PMID: 27196588 DOI: 10.1136/gutjnl-2015-311278] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
100 Bulliard J, Garcia M, Blom J, Senore C, Mai V, Klabunde C. Sorting out measures and definitions of screening participation to improve comparability: The example of colorectal cancer. European Journal of Cancer 2014;50:434-46. [DOI: 10.1016/j.ejca.2013.09.015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
101 Blumenstein I, Tacke W, Bock H, Filmann N, Lieber E, Zeuzem S, Trojan J, Herrmann E, Schröder O. Prevalence of colorectal cancer and its precursor lesions in symptomatic and asymptomatic patients undergoing total colonoscopy: results of a large prospective, multicenter, controlled endoscopy study. Eur J Gastroenterol Hepatol 2013;25:556-61. [PMID: 23283303 DOI: 10.1097/MEG.0b013e32835d1ef4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
102 Senore C, Ederle A, Fantin A, Andreoni B, Bisanti L, Grazzini G, Zappa M, Ferrero F, Marutti A, Giuliani O, Armaroli P, Segnan N. Acceptability and side-effects of colonoscopy and sigmoidoscopy in a screening setting. J Med Screen. 2011;18:128-134. [PMID: 22045821 DOI: 10.1258/jms.2011.010135] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
103 Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Andriole GL, Buys SS, Crawford ED, Fouad MN, Isaacs C, Johnson CC, Reding DJ, O'Brien B, Carrick DM, Wright P, Riley TL, Purdue MP, Izmirlian G, Kramer BS, Miller AB, Gohagan JK, Prorok PC, Berg CD; PLCO Project Team. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012;366:2345-2357. [PMID: 22612596 DOI: 10.1056/nejmoa1114635] [Cited by in Crossref: 599] [Cited by in F6Publishing: 295] [Article Influence: 66.6] [Reference Citation Analysis]
104 Quintero E. Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening? Gastroenterol Hepatol. 2009;32:565-576. [PMID: 19577340 DOI: 10.1016/j.gastrohep.2009.01.179] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
105 Yoon JY, Cha JM, Jeen YT; Quality Improvement Committee of Korean Society of Gastrointestinal Endoscopy (KSGE) and Medical Policy Committee of Korean Association for the Study of Intestinal Research (KASID). [Quality is the Key for Emerging Issues of Population-based Colonoscopy Screening]. Korean J Gastroenterol 2018;71:3-9. [PMID: 29361807 DOI: 10.4166/kjg.2018.71.1.3] [Reference Citation Analysis]
106 Navarro M, Nicolas A, Ferrandez A, Lanas A. Colorectal cancer population screening programs worldwide in 2016: An update. World J Gastroenterol 2017; 23(20): 3632-3642 [PMID: 28611516 DOI: 10.3748/wjg.v23.i20.3632] [Cited by in CrossRef: 202] [Cited by in F6Publishing: 163] [Article Influence: 50.5] [Reference Citation Analysis]
107 Silva-Illanes N, Espinoza M. Critical Analysis of Markov Models Used for the Economic Evaluation of Colorectal Cancer Screening: A Systematic Review. Value Health 2018;21:858-73. [PMID: 30005759 DOI: 10.1016/j.jval.2017.11.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
108 Gingold-Belfer R, Leibovitzh H, Boltin D, Issa N, Tsadok Perets T, Dickman R, Niv Y. The compliance rate for the second diagnostic evaluation after a positive fecal occult blood test: A systematic review and meta-analysis. United European Gastroenterol J 2019;7:424-48. [PMID: 31019712 DOI: 10.1177/2050640619828185] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
109 Gupta S, Halm EA, Rockey DC, Hammons M, Koch M, Carter E, Valdez L, Tong L, Ahn C, Kashner M. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med. 2013;173:1725-1732. [PMID: 23921906 DOI: 10.1001/jamainternmed.2013.9294] [Cited by in Crossref: 19] [Cited by in F6Publishing: 105] [Article Influence: 2.7] [Reference Citation Analysis]
110 Parente F, Marino B, Ardizzoia A, Ucci G, Ilardo A, Limonta F, Villani P, Moretti R, Zucchi A, Cremaschini M. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province. Am J Gastroenterol. 2011;106:1986-1993. [PMID: 21670773 DOI: 10.1038/ajg.2011.185] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
111 Hassan C, Pickhardt PJ, Rex DK. Performance improvements of imaging-based screening tests. Best Pract Res Clin Gastroenterol. 2010;24:493-507. [PMID: 20833352 DOI: 10.1016/j.bpg.2010.04.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
112 Tárraga López PJ, Albero JS, Rodríguez-Montes JA. Primary and secondary prevention of colorectal cancer. Clin Med Insights Gastroenterol 2014;7:33-46. [PMID: 25093007 DOI: 10.4137/CGast.S14039] [Cited by in Crossref: 36] [Cited by in F6Publishing: 51] [Article Influence: 5.1] [Reference Citation Analysis]
113 Hassan C, Hunink MGM, Laghi A, Pickhardt PJ, Zullo A, Kim DH, Iafrate F, Di Giulio E. Value-of-Information Analysis to Guide Future Research in Colorectal Cancer Screening. Radiology 2009;253:745-52. [DOI: 10.1148/radiol.2533090234] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
114 Aihara H, Tajiri H, Schneider M, Charton J, Neuhaus H. Colon Capsule Endoscopy in Screening and Surveillance for Polyps and Cancers. In: Keuchel M, Hagenmüller F, Tajiri H, editors. Video Capsule Endoscopy. Berlin: Springer Berlin Heidelberg; 2014. pp. 495-505. [DOI: 10.1007/978-3-662-44062-9_47] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
115 Schreuders EH, Ruco A, Rabeneck L, Schoen RE, Sung JJ, Young GP, Kuipers EJ. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64:1637-1649. [PMID: 26041752 DOI: 10.1136/gutjnl-2014-309086] [Cited by in Crossref: 508] [Cited by in F6Publishing: 486] [Article Influence: 84.7] [Reference Citation Analysis]
116 Atkin W, Cross AJ, Kralj-Hans I, MacRae E, Piggott C, Pearson S, Wooldrage K, Brown J, Lucas F, Prendergast A, Marchevsky N, Patel B, Pack K, Howe R, Skrobanski H, Kerrison R, Swart N, Snowball J, Duffy SW, Morris S, von Wagner C, Halloran S. Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study. Health Technol Assess 2019;23:1-84. [PMID: 30618357 DOI: 10.3310/hta23010] [Cited by in Crossref: 46] [Cited by in F6Publishing: 18] [Article Influence: 46.0] [Reference Citation Analysis]
117 Lieberman D. Colorectal Cancer Screening in Primary Care. Gastroenterology 2007;132:2591-4. [DOI: 10.1053/j.gastro.2007.04.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
118 Bénard F, Barkun AN, Martel M, von Renteln D. Systematic review of colorectal cancer screening guidelines for average-risk adults: Summarizing the current global recommendations. World J Gastroenterol 2018; 24(1): 124-138 [PMID: 29358889 DOI: 10.3748/wjg.v24.i1.124] [Cited by in CrossRef: 90] [Cited by in F6Publishing: 78] [Article Influence: 30.0] [Reference Citation Analysis]
119 Spada C, Hassan C, Ingrosso M, Repici A, Riccioni ME, Pennazio M, Pirozzi GA, Pagano N, Cesaro P, Spera G, Petruzziello L, Costamagna G. A new regimen of bowel preparation for PillCam colon capsule endoscopy: A pilot study. Digestive and Liver Disease 2011;43:300-4. [DOI: 10.1016/j.dld.2010.10.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
120 Robb KA, Solarin I, Power E, Atkin W, Wardle J. Attitudes to colorectal cancer screening among ethnic minority groups in the UK. BMC Public Health 2008;8:34. [PMID: 18221519 DOI: 10.1186/1471-2458-8-34] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
121 Sali L, Mascalchi M, Falchini M, Ventura L, Carozzi F, Castiglione G, Delsanto S, Mallardi B, Mantellini P, Milani S, Zappa M, Grazzini G; SAVE study investigators. Reduced and Full-Preparation CT Colonography, Fecal Immunochemical Test, and Colonoscopy for Population Screening of Colorectal Cancer: A Randomized Trial. J Natl Cancer Inst. 2016;108. [PMID: 26719225 DOI: 10.1093/jnci/djv319] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 7.0] [Reference Citation Analysis]
122 Senore C, Malila N, Minozzi S, Armaroli P. How to enhance physician and public acceptance and utilisation of colon cancer screening recommendations. Best Pract Res Clin Gastroenterol. 2010;24:509-520. [PMID: 20833353 DOI: 10.1016/j.bpg.2010.06.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
123 Liedenbaum MH, van Rijn AF, de Vries AH, Dekker HM, Thomeer M, van Marrewijk CJ, Hol L, Dijkgraaf MG, Fockens P, Bossuyt PM, Dekker E, Stoker J. Using CT colonography as a triage technique after a positive faecal occult blood test in colorectal cancer screening. Gut 2009;58:1242-9. [PMID: 19625276 DOI: 10.1136/gut.2009.176867] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
124 Khalid-de Bakker CA, Jonkers DM, Hameeteman W, de Ridder RJ, Masclee AA, Stockbrügger RW. Opportunistic screening of hospital staff using primary colonoscopy: participation, discomfort and willingness to repeat the procedure. Digestion. 2011;84:281-288. [PMID: 22041853 DOI: 10.1159/000327383] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
125 Travis E, Ashley L, Pownall M, O'Connor DB. Barriers to flexible sigmoidoscopy colorectal cancer screening in low uptake socio-demographic groups: A systematic review. Psychooncology 2020;29:1237-47. [PMID: 32539187 DOI: 10.1002/pon.5443] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
126 Vleugels JL, van Lanschot MC, Dekker E. Colorectal cancer screening by colonoscopy: putting it into perspective: CRC screening by colonoscopy. Digestive Endoscopy 2016;28:250-9. [DOI: 10.1111/den.12533] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
127 Binefa G, Rodríguez-Moranta F, Teule &, Medina-Hayas M. Colorectal cancer: From prevention to personalized medicine. World J Gastroenterol 2014; 20(22): 6786-6808 [PMID: 24944469 DOI: 10.3748/wjg.v20.i22.6786] [Cited by in CrossRef: 155] [Cited by in F6Publishing: 145] [Article Influence: 22.1] [Reference Citation Analysis]
128 Zorzi M, Hassan C, Capodaglio G, Fedato C, Montaguti A, Turrin A, Rosano A, Monetti D, Stocco C, Baracco S, Russo F, Repici A, Rugge M. Long-term performance of colorectal cancer screening programmes based on the faecal immunochemical test. Gut 2018;67:2124-30. [DOI: 10.1136/gutjnl-2017-314753] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
129 de Vries HS, Boerma D, Timmer R, van Ramshorst B, Dieleman LA, van Westreenen HL. Routine colonoscopy is not required in uncomplicated diverticulitis: a systematic review. Surg Endosc. 2014;28:2039-2047. [PMID: 24488358 DOI: 10.1007/s00464-014-3447-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
130 Cao Y, Zhao G, Yuan M, Liu X, Ma Y, Cao Y, Miao B, Zhao S, Li D, Xiong S, Zheng M, Fei S. KCNQ5 and C9orf50 Methylation in Stool DNA for Early Detection of Colorectal Cancer. Front Oncol 2020;10:621295. [PMID: 33585248 DOI: 10.3389/fonc.2020.621295] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
131 Iussich G, Correale L, Senore C, Hassan C, Segnan N, Campanella D, Bert A, Galatola G, Laudi C, Regge D. Computer-Aided Detection for Computed Tomographic Colonography Screening: A Prospective Comparison of a Double-Reading Paradigm With First-Reader Computer-Aided Detection Against Second-Reader Computer-Aided Detection. Investigative Radiology 2014;49:173-82. [DOI: 10.1097/rli.0000000000000009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
132 Quintero E, Hassan C, Senore C, Saito Y. Progress and challenges in colorectal cancer screening. Gastroenterol Res Pract. 2012;2012:846985. [PMID: 22548053 DOI: 10.1155/2012/846985] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
133 Wong MC, Ching JYL, Chan VCW, Lam TYT, Luk AKC, Ng SC, Ng SSM, Sung JJY. Informed Choice vs. No Choice in Colorectal Cancer Screening Tests: A Prospective Cohort Study in Real-Life Screening Practice. American Journal of Gastroenterology 2014;109:1072-9. [DOI: 10.1038/ajg.2014.136] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
134 Cross AJ, Wooldrage K, Robbins EC, Kralj-Hans I, MacRae E, Piggott C, Stenson I, Prendergast A, Patel B, Pack K, Howe R, Swart N, Snowball J, Duffy SW, Morris S, von Wagner C, Halloran SP, Atkin WS. Faecal immunochemical tests (FIT) versus colonoscopy for surveillance after screening and polypectomy: a diagnostic accuracy and cost-effectiveness study. Gut 2019;68:1642-52. [PMID: 30538097 DOI: 10.1136/gutjnl-2018-317297] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
135 Chacko L, Macaron C, Burke CA. Colorectal Cancer Screening and Prevention in Women. Dig Dis Sci 2015;60:698-710. [DOI: 10.1007/s10620-014-3452-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
136 El Zanati H, Chen A, Attiya A, Leung E. Is routine colonoscopy necessary for patients who have an unequivocal computerised tomography diagnosis of acute diverticulitis? Scott Med J 2021;66:11-5. [PMID: 32781909 DOI: 10.1177/0036933020949228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
137 Mavranezouli I, East JE, Taylor SA. CT colonography and cost-effectiveness. Eur Radiol 2008;18:2485-97. [DOI: 10.1007/s00330-008-1058-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
138 Stracci F, Zorzi M, Grazzini G. Colorectal cancer screening: tests, strategies, and perspectives. Front Public Health. 2014;2:210. [PMID: 25386553 DOI: 10.3389/fpubh.2014.00210] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 6.7] [Reference Citation Analysis]
139 Robertson DJ, Lee JK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Lieberman D, Levin TR, Rex DK. Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on colorectal cancer. Gastrointest Endosc 2017;85:2-21.e3. [PMID: 27769516 DOI: 10.1016/j.gie.2016.09.025] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
140 Adler SN, Hassan C, Metzger Y, Sompolinsky Y, Spada C. Second-generation colon capsule endoscopy is feasible in the out-of-clinic setting. Surg Endosc. 2014;28:570-575. [PMID: 24043646 DOI: 10.1007/s00464-013-3206-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
141 Rosso C, Cabianca L, Gili FM. Non-invasive markers to detect colorectal cancer in asymptomatic population. Minerva Biotecnol 2019;31. [DOI: 10.23736/s1120-4826.18.02493-x] [Cited by in Crossref: 6] [Article Influence: 3.0] [Reference Citation Analysis]
142 Rottier SJ, van Dijk ST, van Geloven AAW, Schreurs WH, Draaisma WA, van Enst WA, Puylaert JBCM, de Boer MGJ, Klarenbeek BR, Otte JA, Felt RJF, Boermeester MA. Meta-analysis of the role of colonoscopy after an episode of left-sided acute diverticulitis. Br J Surg. 2019;106:988-997. [PMID: 31260589 DOI: 10.1002/bjs.11191] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 15.0] [Reference Citation Analysis]
143 Gawron AJ, Jung B, Fought AJ, Waldman BH, Parikh ND. A colorectal cancer screening program in an underserved, ethnically diverse population in Chicago, IL. J Community Health 2013;38:603-8. [PMID: 23471656 DOI: 10.1007/s10900-013-9665-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
144 Castells A, Quintero E. Programmatic screening for colorectal cancer: the COLONPREV study. Dig Dis Sci. 2015;60:672-680. [PMID: 25492501 DOI: 10.1007/s10620-014-3446-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]